Basel, Switzerland- Roche is one step closer to gaining FDA approval for Xolair® (omalizumab). The agency accepts its supplemental Biologics License Application (sBLA) un...
ALBANY, NY – AngioDynamics, a prominent medical technology company dedicated to enhancing blood flow, expanding cancer treatment options, and improving patient quality of...
San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software fea...
Franklin Lakes, NJ – BD (Becton, Dickinson, and Company), a prominent global medical technology company, has secured 510(k) clearances from the U.S. Federal Drug Administ...
Understanding the Impact on Revenue, Efficiency, and Patient Satisfaction. In healthcare, the hub-and-spoke model has emerged both as a strategic solution and a challe...
Tokyo- Olympus Corporation, a global MedTech leader, has received verification from the Science Based Targets initiative (SBTi) for its ambitious net-zero greenhouse gas...
New York- Pfizer Inc. has announced promising topline data from its Phase 2b clinical trial (NCT04707313) evaluating the oral Glucagon-like peptide-1 receptor agonist (GL...
INDIANAPOLIS: Eli Lilly and Company’s (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide) injection, has received the green light from the U.S. Food and Dru...
The World Health Organization (WHO) and UN partners have released the first progress report for the UN Decade of Healthy Ageing. The report highlights efforts to improve...